Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2003
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1341923A2 Methods for enhancing the efficacy of cancer therapy
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341909A2 A method for in vitro molecular evolution of protein function
09/10/2003EP1341908A2 Targeted enzyme prodrug therapy
09/10/2003EP1341907A2 Target enzymes
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341781A1 Antimicrobial quinolones
09/10/2003EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/10/2003EP1341778A1 Klainetin and derivatives thereof, method for their production and the use of the same
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
09/10/2003EP1341759A2 3-substituted oxindole beta 3 agonists
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341553A1 Silensed anti-cd28 antibodies and use thereof
09/10/2003EP1341551A2 Treatment of posterior capsule opacification
09/10/2003EP1341549A2 Combination therapy for estrogen-dependent disorders
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341535A2 Skin whiteners containing hydroxytetronic acid
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341524A2 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1341412A1 Indolocarbazole anticancer agents and methods of using them
09/10/2003EP1312373A8 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1181030B1 Tanacetum parthenium extract
09/10/2003EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
09/10/2003EP1135139B1 Micronized eplerenone compositions
09/10/2003EP1094813B1 Use of piperine and derivatives thereof for treating skin pigmentation disorders and skin cancer
09/10/2003EP1091948B9 Tubulin binding compounds (cobra)
09/10/2003EP1090021B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1047449B1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
09/10/2003EP1035835B1 Long acting injectable formulations containing hydrogenated castor oil
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0996454B1 Use of polyallylamine polymers for the manufacture of a medicament for treating hypercholesterolemia
09/10/2003EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
09/10/2003EP0984938B1 Cyanoguanidines as cell proliferation inhibitors
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0921806B1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441799A New thiochromane derivatives and use as thrombin inhibitors
09/10/2003CN1441798A Thiophene vitamine A
09/10/2003CN1441794A Lipid-rich plague inhibitors
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441780A Piperidine compounds for use as CCR-3 inhibitors
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1441777A Inhibiting angiogenesis and tumor growth
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/10/2003CN1441774A Novel dicarboxylic acid derivatives
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441679A Compositions containing therapentically active components having enhanced solubility
09/10/2003CN1441678A Compounds with sulphonamide group and pharmaceutical compositions containing these compounds
09/10/2003CN1441676A Method of treatment using ligand-immunogen conjugates
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1441671A Fatty acid analogues for treatment of cancer
09/10/2003CN1441664A Synergistic antiplaque/antigivitis oral composition
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440772A Composite Chinese medicine for treating bloat and its prepn process and quality control method
09/10/2003CN1440751A Matrix metal proteinase and tumor necrosis inhibitor
09/10/2003CN1440666A Anti-fatigue male's health tea its production process
09/10/2003CN1120842C New thiazole benzimidazole derivative
09/10/2003CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents
09/10/2003CN1120711C Detoxication tea for cleaning intestine
1 ... 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 ... 1564